{"id":15792,"date":"2014-09-12T10:41:21","date_gmt":"2014-09-12T09:41:21","guid":{"rendered":"https:\/\/psnc.wpengine.com\/?page_id=15792"},"modified":"2025-05-22T16:15:33","modified_gmt":"2025-05-22T15:15:33","slug":"funding-distribution","status":"publish","type":"page","link":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/pharmacy-funding\/funding-distribution\/","title":{"rendered":"Funding distribution"},"content":{"rendered":"

Funding for the contractual framework is distributed through various fees and allowances along with a guaranteed element of retained buying margin. Individual pharmacies\u2019 income may vary according to the mix of products dispensed and the number of additional fees earned, for example, for dispensing controlled drugs and expensive prescription items.<\/p>\n

The following sections contain payment level \/ fee level information for the various elements of contractual framework funding.<\/p>\n

Essential Services<\/a><\/h2>\n

This section includes details on current fee levels for dispensing.<\/p>\n

Advanced Services<\/a><\/h2>\n

This section includes details on payments for NMS, AURs and other services that contractors can choose to provide.<\/p>\n

Retained buying margin (Category M)<\/a><\/h2>\n

This section contains details on the national retained buying margin arrangements and Category M.<\/p>\n

IT\/EPS allowances<\/a><\/h2>\n

This section contains details on IT\/EPS allowances.<\/p>\n

Indicative Income Tables<\/a><\/h2>\n

This section contains tables showing how much an \u2018average\u2019 pharmacy might expect to earn through dispensing fees and retained buying margin, for a given volume of dispensing.<\/p>\n

Summary of funding changes<\/a><\/h2>\n

This section shows fee level adjustments and Category M adjustments over time.<\/p>\n

Other topical payment issues<\/h2>\n